Rat CXCL2/GRO beta/MIP-2/CINC-3 Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 2 publications

Brand:  R&D Systems MAB525

Product Code. 18102221

Description

CXCL2/GRO beta/MIP-2/CINC-3 Monoclonal specifically detects CXCL2/GRO beta/MIP-2/CINC-3 in Rat samples. It is validated for Western Blot, Neutralization, ELISA Capture (Matched Antibody Pair).

Specifications

• Antigen: CXCL2/GRO beta/MIP-2/CINC-3
• Classification: Monoclonal
• Conjugate: Unconjugated
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
• Gene Alias: chemokine (C-X-C motif) ligand 2, CINC-2a, CINC3, CINC-3, C-X-C Motif Chemokine 2, GRO beta, GRO2, GRO2 oncogene, GROb, Gro-beta, Growth-regulated protein beta, Macrophage inflammatory protein 2-alpha, melanoma growth stimulatory activity beta, MGSA beta, MGSA-b, MGSA-beta, MIP2, MIP-2, MIP-2a, MIP2A, MIP2-alpha, SCYB2
• Host Species: Mouse
• Purification Method: Protein A or G purified from hybridoma culture supernatant
• Regulatory Status: RUO
• Gene ID (Entrez): 2920
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
• Isotype: IgG2b

• Applications: Western Blot, Neutralization, ELISA
• Clone: 123802
• Dilution: Western Blot 1 ug/mL, Neutralization 0.4-2.0 ug/mL, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL
• Gene Accession No.: P30348
• Gene Symbols: CXCL2
• Immunogen: E. coli-derived recombinant rat CXCL2/GRO beta/MIP-2/CINC-3 Ser32-Asn100 Accession # P30348
• Quantity: 500 μg
• Primary or Secondary: Primary
• Test Specificity: Detects rat CXCL2/GRO beta/MIP-2/CINC-3 in ELISAs and Western blots. In sandwich ELISAs, less than 0.5% cross-reactivity with recombinant rat (rr) CXCL3 and less than 0.1% cross-reactivity with rrCXCL1, rrCINC-2 alpha , recombinant mouse (rm) CXCL9 or rmCXCL2 is observed. In Western blots, less than 3% cross-reactivity with recombinant human (rh) CXCL8, recombinant porcine CXCL8, or rrCINC-2 alpha and no cross-reactivity with rrCXCL1, 3, rmCXCL1, 2, 6, 9, 10, 12, rhCXLC1, 2, 3, 5, 6, 7, 9,10, 11, 12 or 13 is observed.
• Target Species: Rat
• Form: Purified